Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharina Lückerath

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Clinical Nuclear Medicine|May 31, 2014
FDG PET/CT depicts cutaneous plasmocytomaConstantin Lapa, Stefan Knop, Katharina Lückerath
PET Clinics|March 29, 2023
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination TreatmentKatharina Lückerath, Marija Trajkovic-Arsic, Christine E Mona
European Urology|October 13, 2023
A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?Ulrich Krafft, Boris A Hadaschik, Katharina Lückerath, et al.
Journal of Neuroscience Research|April 29, 2008
Runx2 is expressed in human glioma cells and mediates the expression of galectin-3Valentina Vladimirova, Andreas Waha, Katharina Lückerath, et al.
Nuclear Medicine and Biology|April 18, 2021
Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancerMagdalena Staniszewska, Janette Iking, Katharina Lückerath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Immune-Checkpoint Blockade Enhances <sup>225</sup>Ac-PSMA617 Efficacy in a Mouse Model of Prostate CancerJohannes Czernin, Kyle Current, Christine E Mona, et al.
Molecular Pharmaceutics|June 29, 2026
Done EAZY: An Automated Procedure for <sup>89</sup>Zr-Radiolabeling and Size-Exclusion Chromatography Purification of Nanoliposomal Anticancer TherapeuticsJustin Dubbert, Falk Kunkel, Thomas Mühlenberg, et al.
Oncotarget|October 4, 2014
18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantationConstantin Lapa, Katharina Lückerath, Uwe Malzahn, et al.
EJNMMI Research|May 16, 2015
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapyConstantin Lapa, Rudolf A Werner, Christina Bluemel, et al.
Methods (San Diego, Calif.)|September 17, 2017
Chemokine receptor - Directed imaging and therapyAndreas K Buck, Antje Stolzenburg, Heribert Hänscheid, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Clinical Nuclear Medicine|May 31, 2014
FDG PET/CT depicts cutaneous plasmocytomaConstantin Lapa, Stefan Knop, Katharina Lückerath
PET Clinics|March 29, 2023
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination TreatmentKatharina Lückerath, Marija Trajkovic-Arsic, Christine E Mona
European Urology|October 13, 2023
A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?Ulrich Krafft, Boris A Hadaschik, Katharina Lückerath, et al.
Journal of Neuroscience Research|April 29, 2008
Runx2 is expressed in human glioma cells and mediates the expression of galectin-3Valentina Vladimirova, Andreas Waha, Katharina Lückerath, et al.
Nuclear Medicine and Biology|April 18, 2021
Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancerMagdalena Staniszewska, Janette Iking, Katharina Lückerath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Immune-Checkpoint Blockade Enhances <sup>225</sup>Ac-PSMA617 Efficacy in a Mouse Model of Prostate CancerJohannes Czernin, Kyle Current, Christine E Mona, et al.
Molecular Pharmaceutics|June 29, 2026
Done EAZY: An Automated Procedure for <sup>89</sup>Zr-Radiolabeling and Size-Exclusion Chromatography Purification of Nanoliposomal Anticancer TherapeuticsJustin Dubbert, Falk Kunkel, Thomas Mühlenberg, et al.
Oncotarget|October 4, 2014
18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantationConstantin Lapa, Katharina Lückerath, Uwe Malzahn, et al.
EJNMMI Research|May 16, 2015
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapyConstantin Lapa, Rudolf A Werner, Christina Bluemel, et al.
Methods (San Diego, Calif.)|September 17, 2017
Chemokine receptor - Directed imaging and therapyAndreas K Buck, Antje Stolzenburg, Heribert Hänscheid, et al.
Pageof 6